Sio Gene Therapies Inc. (SIOX) Stock Analysis
DELISTED 2024
What happened to Sio Gene Therapies Inc. (SIOX) stock?
Sio Gene Therapies Inc. (SIOX) no longer trades on public markets. It was delisted in February 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- February 2024
- Last recorded price (historical):
- $0.478 (last quote on record before the February 2024 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Sio Gene Therapies Inc. (SIOX). Sio Gene Therapies Inc. is a clinical-stage biotechnology company focused on developing gene therapies for neurodegenerative diseases. Their pipeline includes programs targeting GM1 gangliosidosis and Parkinson's disease.
Last analyzed: Mar 18, 2026Sio Gene Therapies Inc. (SIOX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy SIOX shares?
No. SIOX stopped trading on public markets in February 2024, so the shares are not available through a broker. Anything you see quoted for SIOX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SIOX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Sio Gene Therapies Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.